Introduction to vancomycin infusion advice in adults undergoing dialysis

Vancomycin is commonly used in patients with end-stage kidney disease undergoing haemodialysis. Advice is included in these guidelines for:

The recommendations in this topic apply to patients undergoing high-flux haemodialysis. For patients undergoing low-flux haemodialysis, seek expert advice.

Vancomycin dosing advice for patients with acute kidney injury undergoing haemodialysis is beyond the scope of these guidelines.

In patients on continuous renal replacement therapy (CRRT), vancomycin pharmacokinetics can be difficult to predict and are influenced by CRRT intensity – seek expert advice for information about dosing and monitoring.